Investor Relations


Last $ 182.46
Change 0.12%
11.27.15 1:00 PM ET


Alexion to Highlight Robust Rare Disease Pipeline at Investor Day
Thu, 10 Dec, 2015 - 12:00 PM ET
Listen to Webcast »

Note: Alexion Pharmaceuticals, Inc. provides this data for informational and research purposes only. The data is not intended for trading purposes. Neither Alexion nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.